Condition
Unresectable Colorectal Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Unresectable Colorectal Carcinoma clinical trials that are recruiting, in United States. By phase: Phase 3 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest Unresectable Colorectal Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Understand cancer cachexia subtypes in advanced cancers | — | Pleasanton, California | Recruiting | Aug 20, 2026 |
| Mitomycin PIPAC plus FOLFIRI vs FOLFIRI/bevacizumab for unresectable peritoneal metastases from appendix or colorectal cancer | Phase 3 | Goodyear, Arizona and 4 other locations | Recruiting | Dec 9, 2025 |
| Observational study on cancer cachexia subtypes | — | Fort Smith, Arkansas and 224 other locations | Recruiting | Oct 10, 2023 |
| Testing pump chemotherapy for liver metastases from colorectal cancer | Phase 3 | Birmingham, Alabama and 61 other locations | Recruiting | May 17, 2023 |
| Combining ZEN003694 with Capecitabine for Advanced Cancer Treatment | Phase 1 | Irvine, California and 21 other locations | Recruiting | Apr 7, 2023 |
All recruiting trials (5)
-
Understand cancer cachexia subtypes in advanced cancers
This study tests how cancer cachexia presents in people with advanced colorectal, pancreatic, or lung cancer to see if different subtypes relate to outcomes.
-
Mitomycin PIPAC plus FOLFIRI vs FOLFIRI/bevacizumab for unresectable peritoneal metastases from appendix or colorectal cancer
This phase 3 trial tests whether pressurized intraperitoneal aerosolized chemotherapy with mitomycin, given with systemic FOLFIRI, can help patients with unresectable appendix or colorectal cancer that has spread to the abdominal lining, compared with the standard FOLFIRI plus bevacizumab.
-
Observational study on cancer cachexia subtypes
This study is trying to identify different types of weight and muscle loss in patients with advanced colorectal, lung, or pancreatic cancers to help improve future treatments.
-
Testing pump chemotherapy for liver metastases from colorectal cancer
This study is testing if adding a special type of chemotherapy delivered directly to the liver can help people with colorectal cancer that has spread to the liver live longer and have fewer problems compared to standard chemotherapy alone.
-
Combining ZEN003694 with Capecitabine for Advanced Cancer Treatment
This study is testing a new combination of two cancer drugs, ZEN003694 and capecitabine, to see if it can help people with advanced cancers that haven't responded to other treatments.
Related topics
Quick answers
How many Unresectable Colorectal Carcinoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.